Lonza will provide process development and cGMP manufacturing services for preclinical and Phase 1 studies of Opsona Therapeutics monoclonal antibody OPN- 305, using its GS Gene Expression System.
Morning Star
Sunday 1 March 2009
Lonza to manufacture Opsona antibody
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment